• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION, INC. LVIS JR 2.5X23 MM; STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION, INC. LVIS JR 2.5X23 MM; STENT Back to Search Results
Model Number 172020-CASJ
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombus (2101)
Event Date 07/14/2019
Event Type  Injury  
Manufacturer Narrative
The lot number was not provided; therefore, a search for production-related ncrs could not be performed.The stent was implanted in the patient and the remainder of the device was not returned to the manufacturer; therefore, a product analysis could not be performed.The root cause is unknown.The instructions for use (ifu) identifies thrombus as a potential complication associated with use of the device.
 
Event Description
It was reported that a patient enrolled in the lepi clinical trial was treated with an lvis stent for a recanalized saccular acomm artery aneurysm that had never ruptured and was previously treated with embolization coils.During the procedure, angiographic imaged demonstrated multiple small thrombus in the stent.Circulation in the anterior cerebral artery was still maintained.An iv bolus of reopro (25mg/kg) was administered intravenously.The patient's outcome was reported to be "resolved without sequelae on the same day." the patient was reported to be asymptomatic and was discharged with a mrs=0.The patient will continue to be monitored per clinical trial protocol.
 
Manufacturer Narrative
A search for non-conformances associated with this part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.B5: additional information: the procedure report was received from the clinical site on (b)(6) 2019.Additional details indicate that the a-com aneurysm had a wide neck and stent-assisted coiling was performed, aided by the implantation of an lvis jr.Stent.The patient was placed on dual antiplatelet therapy for 3 months, followed by kargegic alone for up to one year.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LVIS JR 2.5X23 MM
Type of Device
STENT
Manufacturer (Section D)
MICROVENTION, INC.
35 enterprise drive
aliso viejo CA 92656
MDR Report Key8923827
MDR Text Key155325145
Report Number2032493-2019-00200
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
PMA/PMN Number
K130005
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 07/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/22/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date09/30/2020
Device Model Number172020-CASJ
Device Catalogue Number17100352A
Was Device Available for Evaluation? No
Date Manufacturer Received07/26/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age48 YR
-
-